Special Reports 09 Jul 2018 Strong returns for AusCann investors Bookmark Save articles for future reference. Subscribe to BN Log In Share to Facebook X LinkedIn SPECIAL REPORT: AusCann has benefited from a wave of interest in medicinal cannabis for pain relief to be the BN30's top performer in shareholder returns for the year to June 30.